Optellum, a high-tech startup in lung cancer and machine learning, and Mirada Medical recently announced a partnership to accelerate the deployment of deep learning technology to market. This collaboration combines the deep technology and clinical expertise of Optellum with the software platforms and rapid development know-how of Mirada. They have partnered to address what they call a huge and growing problem in lung cancer diagnosis: the management of patients with indeterminate pulmonary nodules.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now